Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132548) titled 'Study on Individualized Dosing of Linezolid' on Sept. 15.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Huashan Hospital, Fudan University
Condition:
Bacterial infection
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-10-01
Target Sample Size: TDM group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343558
Published by HT Digital Content Services with permission from Health Daily Digest....